According to the Zhitong Finance App, Emmy Vaccine (06660.HK) announced interim results for the six months ended June 30, 2026. The group obtained revenue of 351 million yuan; the owner of the parent company should have accounted for a loss of 123 million yuan%; and a loss of 0.1 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.